Programmed Cell Death-ligand 1 as Biomarker of Poor Prognosis in Patients with Gastrointestinal Stromal Tumour
The results suggest that overexpression of PD-L1 is a risk factor for a poor prognosis in patients with GISTs. Knockdown of PD-L1 significantly inhibited the development of GISTs. PD-L1 may serve as a biomarker for the poor prognosis of GISTs and a potential therapeutic target.
Authors
- Abuduwaili Aierken
- Duolikun Yasheng
- Abudureyimu Kelimu (ORCID: https://orcid.org/0000-0001-6814-2062)
- Yiliang Li (ORCID: https://orcid.org/0000-0002-3592-6167)
- Aikebaier Aili
Institutions
- Xinjiang Medical University (CN)
- People's Hospital of Xinjiang Uygur Autonomous Region (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Gastrointestinal and Liver Diseases
- Published
- 2025-03-27
- DOI
- https://doi.org/10.15403/jgld-5858
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00